RNA vaccine technology has emerged as a groundbreaking approach in the field of immunology and infectious disease prevention.
In this article, ReiThera's scientific and operational leaders discuss ReiThera’s proprietary platforms, process development ...
With their promise to transform disease trajectories, cell and gene therapies (CGTs) are bringing new hope to patients with ...
In this interview, Dr. Kelemen discusses the advantages of lipid-based delivery systems and their potential to expand the ...
Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Humane Genomics, a biotechnology company developing oncolytic viral therapies, today announced a ...
Applied StemCell, Inc. (ASC), today announced the successful knock-in of a 50 kilobase (kb) multifunctional DNA insert into human induced pluripotent stem cells (iPSCs) using its proprietary TARGATT™ ...
The global vaccines market is projected to grow from USD 50.46 billion in 2025 to USD 63.66 billion by 2030, achieving a CAGR ...
Comprehensive immunogenicity data of individualized neoantigen therapeutic vaccine (INTV) TG4050, from the randomized Phase I study in operable ...
It also establishes a framework to progress IND-enabling studies, scale clinical-grade vector manufacturing, conduct regulatory submissions to the U.S. FDA and the Saudi FDA, and initiate a Phase 1/2a ...
Hosted on MSN
Testing viral TikTok gadgets that really work
Adam B tests viral TikTok gadgets to see if they actually work. Rand Paul: 'All of these people have been blown up without us knowing their name' Cargo Theft Hits Record Levels Amid Tariffs NFL team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback